The porcupine inhibitor LGK974 reduces Wnt signaling and decreased expression of ALDH3A1 mRNA and protein in glioma cells, thereby increasing their susceptibility to TMZ treatment. This evidence concerns the gene ALDH3A1 and central nervous system cancer.